Annual D&A:
$233.00K+$115.00K(+97.46%)Summary
- As of today, CDTX annual D&A is $233.00 thousand, with the most recent change of +$115.00 thousand (+97.46%) on December 31, 2024.
- During the last 3 years, CDTX annual D&A has risen by +$44.00 thousand (+23.28%).
- CDTX annual D&A is now -68.17% below its all-time high of $732.00 thousand, reached on December 31, 2016.
Performance
CDTX Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$28.00K+$1000.00(+3.70%)Summary
- As of today, CDTX quarterly D&A is $28.00 thousand, with the most recent change of +$1000.00 (+3.70%) on September 30, 2025.
- Over the past year, CDTX quarterly D&A has dropped by -$33.00 thousand (-54.10%).
- CDTX quarterly D&A is now -85.86% below its all-time high of $198.00 thousand, reached on March 31, 2017.
Performance
CDTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$163.00K-$33.00K(-16.84%)Summary
- As of today, CDTX TTM D&A is $163.00 thousand, with the most recent change of -$33.00 thousand (-16.84%) on September 30, 2025.
- Over the past year, CDTX TTM D&A has dropped by -$50.00 thousand (-23.47%).
- CDTX TTM D&A is now -78.30% below its all-time high of $751.00 thousand, reached on March 31, 2017.
Performance
CDTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CDTX Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +97.5% | -54.1% | -23.5% |
| 3Y3 Years | +23.3% | -24.3% | +8.0% |
| 5Y5 Years | -29.0% | -63.2% | -44.9% |
CDTX Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +97.5% | -54.1% | +27.3% | -30.0% | +50.9% |
| 5Y | 5-Year | -29.0% | +97.5% | -63.2% | +27.3% | -44.9% | +50.9% |
| All-Time | All-Time | -68.2% | >+9999.0% | -85.9% | >+9999.0% | -78.3% | >+9999.0% |
CDTX Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $28.00K(+3.7%) | $163.00K(-16.8%) |
| Jun 2025 | - | $27.00K(-44.9%) | $196.00K(-13.3%) |
| Mar 2025 | - | $49.00K(-16.9%) | $226.00K(-3.0%) |
| Dec 2024 | $233.00K(+97.5%) | $59.00K(-3.3%) | $233.00K(+9.4%) |
| Sep 2024 | - | $61.00K(+7.0%) | $213.00K(+22.4%) |
| Jun 2024 | - | $57.00K(+1.8%) | $174.00K(+22.5%) |
| Mar 2024 | - | $56.00K(+43.6%) | $142.00K(+20.3%) |
| Dec 2023 | $118.00K(-17.5%) | $39.00K(+77.3%) | $118.00K(+9.3%) |
| Sep 2023 | - | $22.00K(-12.0%) | $108.00K(-12.2%) |
| Jun 2023 | - | $25.00K(-21.9%) | $123.00K(-9.6%) |
| Mar 2023 | - | $32.00K(+10.3%) | $136.00K(-4.9%) |
| Dec 2022 | $143.00K(-24.3%) | $29.00K(-21.6%) | $143.00K(-5.3%) |
| Sep 2022 | - | $37.00K(-2.6%) | $151.00K(-5.0%) |
| Jun 2022 | - | $38.00K(-2.6%) | $159.00K(-7.0%) |
| Mar 2022 | - | $39.00K(+5.4%) | $171.00K(-9.5%) |
| Dec 2021 | $189.00K(-33.9%) | $37.00K(-17.8%) | $189.00K(-13.7%) |
| Sep 2021 | - | $45.00K(-10.0%) | $219.00K(-12.4%) |
| Jun 2021 | - | $50.00K(-12.3%) | $250.00K(-8.1%) |
| Mar 2021 | - | $57.00K(-14.9%) | $272.00K(-4.9%) |
| Dec 2020 | $286.00K(-12.8%) | $67.00K(-11.8%) | $286.00K(-3.4%) |
| Sep 2020 | - | $76.00K(+5.6%) | $296.00K(-1.7%) |
| Jun 2020 | - | $72.00K(+1.4%) | $301.00K(-3.8%) |
| Mar 2020 | - | $71.00K(-7.8%) | $313.00K(-4.6%) |
| Dec 2019 | $328.00K | $77.00K(-4.9%) | $328.00K(-9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $81.00K(-3.6%) | $362.00K(-13.4%) |
| Jun 2019 | - | $84.00K(-2.3%) | $418.00K(-11.1%) |
| Mar 2019 | - | $86.00K(-22.5%) | $470.00K(-10.1%) |
| Dec 2018 | $523.00K(-21.6%) | $111.00K(-19.0%) | $523.00K(-5.1%) |
| Sep 2018 | - | $137.00K(+0.7%) | $551.00K(-1.3%) |
| Jun 2018 | - | $136.00K(-2.2%) | $558.00K(-8.2%) |
| Mar 2018 | - | $139.00K(0.0%) | $608.00K(-8.8%) |
| Dec 2017 | $667.00K(-8.9%) | $139.00K(-3.5%) | $667.00K(-6.5%) |
| Sep 2017 | - | $144.00K(-22.6%) | $713.00K(-4.6%) |
| Jun 2017 | - | $186.00K(-6.1%) | $747.00K(-0.5%) |
| Mar 2017 | - | $198.00K(+7.0%) | $751.00K(+2.6%) |
| Dec 2016 | $732.00K(+58.8%) | $185.00K(+3.9%) | $732.00K(+1.8%) |
| Sep 2016 | - | $178.00K(-6.3%) | $719.00K(+12.2%) |
| Jun 2016 | - | $190.00K(+6.1%) | $641.00K(+16.8%) |
| Mar 2016 | - | $179.00K(+4.1%) | $549.00K(+19.1%) |
| Dec 2015 | $461.00K(+157.5%) | $172.00K(+72.0%) | $461.00K(+21.6%) |
| Sep 2015 | - | $100.00K(+2.0%) | $379.00K(+8.6%) |
| Jun 2015 | - | $98.00K(+7.7%) | $349.00K(+29.3%) |
| Mar 2015 | - | $91.00K(+1.1%) | $270.00K(+50.8%) |
| Dec 2014 | $179.00K(>+9900.0%) | $90.00K(+28.6%) | $179.00K(+101.1%) |
| Sep 2014 | - | $70.00K(+268.4%) | $89.00K(+368.4%) |
| Jun 2014 | - | $19.00K(>+9900.0%) | $19.00K(>+9900.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $0.00 | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual D&A?
- What is the all-time high annual D&A for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual D&A year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Cidara Therapeutics, Inc. TTM D&A?
- What is the all-time high TTM D&A for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM D&A year-on-year change?
What is Cidara Therapeutics, Inc. annual D&A?
The current annual D&A of CDTX is $233.00K
What is the all-time high annual D&A for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual D&A is $732.00K
What is Cidara Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, CDTX annual D&A has changed by +$115.00K (+97.46%)
What is Cidara Therapeutics, Inc. quarterly D&A?
The current quarterly D&A of CDTX is $28.00K
What is the all-time high quarterly D&A for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly D&A is $198.00K
What is Cidara Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, CDTX quarterly D&A has changed by -$33.00K (-54.10%)
What is Cidara Therapeutics, Inc. TTM D&A?
The current TTM D&A of CDTX is $163.00K
What is the all-time high TTM D&A for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM D&A is $751.00K
What is Cidara Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, CDTX TTM D&A has changed by -$50.00K (-23.47%)